OnCo
ideasIdea

Tailored screening for second cancers in survivors with known high-risk exposures

Survivors who had chest radiotherapy as young women, or certain chemotherapies, have much higher risks of specific second cancers. They should be screened like people with inherited risk, and today most are not.

Women treated with chest radiotherapy before 30 have breast cancer risks comparable to BRCA carriers and are recommended annual MRI; survivors of Hodgkin lymphoma have elevated lung and gastrointestinal cancer risks; alkylating agents raise leukaemia risk. Uptake of recommended surveillance is low because survivors and their doctors do not know the exposures. Registry-driven identification and invitation to tailored screening, as is done for hereditary syndromes, would apply existing evidence.

Hypothesis
Registry-driven invitation will raise adherence to recommended second-cancer surveillance among high-risk survivors from under 40% to above 75%, and will shift second cancers to earlier stage at diagnosis.
Rationale
Organised invitation is what makes population screening work; high-risk survivors are a defined, findable population with strong evidence for surveillance.
What would test it
A randomised trial of registry-driven invitation versus usual care among 5,000 high-risk survivors with adherence and stage at second-cancer diagnosis as endpoints.
Maturity
early clinical
Who has to act
clinic
Cost to try
Medium ($1M to $50M)
Years to first evidence
4
Bottlenecks it attacks

Connected

5top